Home Page
About us
Guangzhou KOFA Biotechnology Co.,Ltd. was founded in 2004, headquartered in Guangzhou High-tech Industry Development Zone, Science City. It is a national high-tech enterprise focusing on the research and development, manufacturing, sales and service of in vitro diagnostic reagents and instruments (IVD). The company has always adhered to the strategy of independent intellectual property rights, independent innovation and independent brand, and has established a biochemical immunoassay assembly line platform, a chemiluminescence detection platform, a fluorescent immunochromatography platform, and a biochemical diagnostic technology platform. It has obtained more than 200 registration certificates, and its detection series covers liver and kidney function, cardiovascular disease, blood lipids, diabetes, genetic diseases, tumors, thyroid function and other fields, and is widely used in medical institutions and third-party testing centers at all levels across the country.
News Center
Compared with traditional IVD products, POCT has three major advantages: short test time, wide detection space, and easy operation. It can meet the needs of fast and timely testing, and has become a revolutionary and rapidly developing sub field in the IV
More+Products
Service Support
KOFA has always upheld the philosophy of “Technology Benefiting All” and has remained steadfast in its commitment to delivering high-quality products and exceptional technical services to customers over the years. Backed by a strong technical support team, we provide professional product consultation, reagent optimization, and comprehensive after-sales services to promptly address any technical issues our customers may encounter during product use.
Contact us
2024-12-10
21 projects and 42 specifications submitted by KOFA Bio were all successfully selected
check the details2024-12-03
The18th Academic Conference on Laboratory Medicine of the Chinese Medical Association (2024 Laboratory Medicine Conference)was successfully held at the Hangzhou International Expo Center in Zhejiang Province
check the details2024-12-02
Review of "Gathering power and win-win" eventOn November 25, the "2024 First Medical Alliance New Ecology Conference & Zhejiang Medical Channel Sharing and Resource Docking Conference", sponsored by the League of Nations Medical In
check the details2024-11-25
KOFA Biologics successfully passed the verification plan of serum biochemical index detection capability organized by the China Institute of Food and Drug Control
check the details2024-11-25
The Fall of 2024 CMEF Medical Equipment Expo was held in Shenzhen on October 12-15. KOFA Biological V919 ultra-high speed chemiluminescence immunoanalyzer attracted the attention of many visitors with its breakthrough technology.
check the details2024-07-04
check the details2024-02-22
Guangdong Provincial High-quality Development ConferenceOn February 18, the first working day of the Lunar New Year, the Guangdong Provincial Party Committee and the Provincial Government held a provincial high-quality development conference, focusing on
check the details2023-01-24
Compared with traditional IVD products, POCT has three major advantages: short test time, wide detection space, and easy operation. It can meet the needs of fast and timely testing, and has become a revolutionary and rapidly developing sub field in the IV
check the details2022-02-28
The market for tests using cardiac biomarkers, including cardiac markers used for heart attack detection, and cholesterol and coagulation tests, surpassed $2 billion in 2015.
check the details2022-02-27
Companies in the global in vitro diagnostic (IVD) market which is currently worth USD 60.5 billion are being affected by various trends such as hospital consolidation, China’s increasingly important role in product launch decisions, service test markets,
check the details